Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background In clinical trials following individuals over a period of time, the same assessment may be made at a number of time points during the course of the trial. Our review of current practice for handling longitudinal data in Cochrane systematic reviews shows that the most frequently used approach is to ignore the correlation between repeated observations and to conduct separate meta-analyses at each of a number of time points. Purpose The purpose of this paper is to show the link between repeated measurement models used with aggregate data and those used when individual patient data (IPD) are available, and provide guidance on the methods that practitioners might use for aggregate data meta-analyses, depending on the type of data available. Methods We discuss models for the meta-analysis of longitudinal continuous outcome data when IPD are available. In these models time is included either as a factor or as a continuous variable, and account is taken of the correlation between repeated observations. The meta-analysis of IPD can be conducted using either a one-step or a two-step approach: the latter involves analysing the IPD separately in each study and then combining the study estimates taking into account their covariance structure. We discuss the link between models for use with aggregate data and the two-step IPD approach, and the problems which arise when only aggregate data are available. The methods are applied to IPD from 5 trials in Alzheimer's disease. Results Two major issues for the meta-analysis of aggregate data are the lack of information about correlation coefficients and the effect of missing data at the patient-level. Application to the Alzheimer's disease data set shows that ignoring correlation can lead to different pooled estimates of the treatment difference and their standard errors. Furthermore, the amount of missing data at the patient level can affect these estimates. Limitations The models assume fixed treatment effects across studies, and that any missing data is missing at random, both at the patient-level and the study level. Conclusions It is preferable to obtain IPD from all studies to correctly account for the correlation between repeated observations. When IPD are not available, the ideal aggregate data are model-based estimates of treatment difference and their variance and covariance estimates. If covariance estimates are not available, sensitivity analyses should be undertaken to investigate the robustness of the results to different amounts of correlation. Clinical Trials 2009; 6: 16—27. http:// ctj.sagepub.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Small sample inference for fixed effects from restricted maximum likelihood
Kenward, M. G., & Roger, J. H. (1997) · Biometrics · doi:10.2307/2533558 · Cited by 4,552 · cited 1×
“SAS PROC MIXED allows the option to inflate the estimated variance of the mean treatment difference to allow for the estimation of the variance and covariance components and to estimate the degrees of freedom for the t-test using Satterthwaite’s procedure [12,13].”
MethodMeta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Self-citationNam, I., Mengersen, K., & Garthwaite, P. (2003) · Statistics in Medicine · doi:10.1002/sim.1410 · Cited by 153
Cited by
Meta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701
Self-citationMobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis
Thakkar, J., Kurup, R., Laba, T.-L., Santo, K., Thiagalingam, A., Rodgers, A., Woodward, M., Redfern, J., & Chow, C. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7667 · Cited by 685
Burke, D. L., Ensor, J., & Riley, R. D. (2017) · Statistics in Medicine · doi:10.1002/sim.7141 · Cited by 538
“These patients responses, and indeed subsequent parameter estimates (such as treatment effects at multiple time points), will be correlated, and ignoring this in the meta-analysis is inadvisable [84,85].”
MethodSelf-citationMultivariate meta‐analysis: Potential and promise
Jackson, D., Riley, R., & White, I. R. (2011) · Statistics in Medicine · doi:10.1002/sim.4172 · Cited by 530
Self-citationHormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis
Morrison, C. S., Chen, P.-L., Kwok, C., Baeten, J. M., Brown, J., Crook, A. M., Van Damme, L., Delany-Moretlwe, S., Francis, S. C., Friedland, B. A., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001778 · Cited by 355
Metadata
- Authors
- Jones, A. P., Riley, R. D., Williamson, P. R., & Whitehead, A.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2009-02
- Volume
- 6
- Issue
- 1
- Pages
- 16-27
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2166747774
- Cited by
- 137
- References
- 3
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. https://app.cochat.ai/papers/10.1177/1740774508100984
- The paper
- Jones, A. P., Riley, R. D., Williamson, P. R., & Whitehead, A. (2009). Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clinical Trials. https://doi.org/10.1177/1740774508100984
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.